Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic
B. M. Mortzfeld, J. D. Palmer, S. K. Bhattarai, H. L. Dupre, R. Mercado-Lubo, M. W. Silby, C. Bang, B. A. McCormick, V. Bucci
This paper demonstrates that engineered live biotherapeutic Escherichia coli producing microcin MccI47 reduces carbapenem-resistant Klebsiella pneumoniae colonization in mice without disrupting the microbiota.
Gut Microbes · Sep 29, 2022Peer-reviewedBioengineering